# Novome Biotechnologies, Inc. — Form D

Novome Biotechnologies, Inc. of DALY CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-10. The offering totals $700K, of which $536K was reported sold. Industry: Other Technology.

## Offering

- Filed: 2017-01-10
- Form: D
- Accession: 0001694013-17-000001
- Industry: Other Technology
- Exemptions: 04, 05, 06b
- Total offering: $700K
- Amount sold: $536K
- Remaining: $164K
- Investors: 10
- Date of first sale: 2016-11-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278006

## Issuer

- Name: Novome Biotechnologies, Inc.
- CIK: 0001694013
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 15 WESTMONT DRIVE, DALY CITY, CA, 94015
- Phone: 650-416-6863

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| William DeLoache | Director | Daly City, CA |
| Samuel Smits | Director | Daly City, CA |
| Elizabeth Stanley | Director | Daly City, CA |
| Weston Whitaker | Director | Daly City, CA |
| Weston Whitaker | Executive Officer | Daly City, CA |
| Weston Whitaker | Promoter | Daly City, CA |

## More

- [CIK 1694013 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1694013&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001694013-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.